These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33139612)

  • 1. Advances and Therapeutic Perspectives in Extended-Stage Small-Cell Lung Cancer.
    Pierret T; Toffart AC; Giaj Levra M; Moro-Sibilot D; Gobbini E
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33139612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy.
    Ragavan M; Das M
    Curr Treat Options Oncol; 2020 Jun; 21(8):64. PubMed ID: 32601742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer.
    Horn L; Reck M; Spigel DR
    Oncologist; 2016 Aug; 21(8):910-21. PubMed ID: 27354668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Strategies for the Treatment of Small Cell Lung Cancer: A Review.
    Petty WJ; Paz-Ares L
    JAMA Oncol; 2023 Mar; 9(3):419-429. PubMed ID: 36520421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update 2021: Management of Small Cell Lung Cancer.
    Tariq S; Kim SY; Monteiro de Oliveira Novaes J; Cheng H
    Lung; 2021 Dec; 199(6):579-587. PubMed ID: 34757446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small cell lung cancer: a slightly less orphan disease after immunotherapy.
    Remon J; Aldea M; Besse B; Planchard D; Reck M; Giaccone G; Soria JC
    Ann Oncol; 2021 Jun; 32(6):698-709. PubMed ID: 33737119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consolidation radiotherapy for patients with extended disease small cell lung cancer in a single tertiary institution: impact of dose and perspectives in the era of immunotherapy.
    Stanic K; Vrankar M; But-Hadzic J
    Radiol Oncol; 2020 Jul; 54(3):353-363. PubMed ID: 32726294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for extensive-stage small-cell lung cancer: current landscape and future perspectives.
    Zhang S; Cheng Y
    Front Oncol; 2023; 13():1142081. PubMed ID: 37188176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy versus standard chemotherapy for treatment of extensive-stage small-cell lung cancer: a systematic review.
    Liu X; Xing H; Zhang H; Liu H; Chen J
    Immunotherapy; 2021 Aug; 13(12):989-1000. PubMed ID: 34114477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs in development for small cell lung cancer.
    Serzan MT; Farid S; Liu SV
    J Thorac Dis; 2020 Oct; 12(10):6298-6307. PubMed ID: 33209468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival in extensive-stage small-cell lung cancer treated with different immune checkpoint inhibitors in multiple-line therapies: A case report and literature review.
    Zhang X; Zheng J; Niu Y; Xue C; Yu Y; Tan K; Cui H
    Front Immunol; 2022; 13():1059331. PubMed ID: 36532013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunotherapy Advances in Small Cell Lung Cancer].
    Xu Y; Zhan P; Song Y
    Zhongguo Fei Ai Za Zhi; 2020 Nov; 23(11):989-998. PubMed ID: 32752583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future therapeutic approaches for the treatment of small cell lung cancer.
    Rossi A; Tay R; Chiramel J; Prelaj A; Califano R
    Expert Rev Anticancer Ther; 2018 May; 18(5):473-486. PubMed ID: 29544351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-Cell Lung Cancer-An Update on Targeted and Immunotherapies.
    McNamee N; da Silva IP; Nagrial A; Gao B
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer.
    Melosky B; Cheema PK; Brade A; McLeod D; Liu G; Price PW; Jao K; Schellenberg DD; Juergens R; Leighl N; Chu Q
    Oncologist; 2020 Nov; 25(11):981-992. PubMed ID: 32860288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status and future perspectives of immune checkpoint inhibitors in extensive-stage small cell lung cancer.
    Liu X; Xing H; Liu B
    Am J Cancer Res; 2022; 12(6):2447-2464. PubMed ID: 35812062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in new targets for immunotherapy of small cell lung cancer.
    Zheng Z; Liu J; Ma J; Kang R; Liu Z; Yu J
    Thorac Cancer; 2024 Jan; 15(1):3-14. PubMed ID: 38093497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficiency and safety of immune checkpoint inhibitors in the treatment of small cell lung cancer: a meta-analysis.
    Zhang S; Bi M
    Ann Palliat Med; 2020 Nov; 9(6):4081-4088. PubMed ID: 33302668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the Biology, Management, and Treatment of Small Cell Lung Cancer (SCLC).
    Saltos A; Shafique M; Chiappori A
    Front Oncol; 2020; 10():1074. PubMed ID: 32766139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment patterns and clinical outcomes of extensive stage small cell lung cancer (SCLC) in the real-world evidence ESME cohort before the era of immunotherapy.
    Valette CA; Filleron T; Debieuvre D; Lena H; Pérol M; Chouaid C; Simon G; Quantin X; Girard N
    Respir Med Res; 2023 Nov; 84():101012. PubMed ID: 37307617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.